文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
S. Lancaster
发表
Phase II study of irinotecan and cetuximab given every 2 weeks as second-line therapy for advanced colorectal cancer.
M. Fakih, B. Carneiro, B. Lembersky, 2012, Clinical colorectal cancer.